AbstractObjective To study the applicability of serum total bile acid (TBA) and N terminal pro B type natriuretic peptide (NT-proBNP) in the assessment of prognosis of patients with chronic heart failure (CHF) complicated with type 2 diabetes (T2DM). Methods A total of 146 CHF patients hospitalized in Beijing Electric Power Hospital between October 2019 and June 2020 were selected and divided into the observation group (n=87) and control group (n=59) according to complications with T2DM. The levels of TBA and NT-proBNP in each group were detected, and the clinical value of TBA, NT-proBNP, and their combined detection in the prognosis assessment of CHF patients with T2DM was analyzed respectively by the ROC curve. Results Compared with the control group, the levels of TBA and NT-proBNP in the observation group were significantly increased (P<0.01). Spearmen grade correlation analysis showed that the cardiac function grade in the observation group was positively correlated with TBA levels (rs=0.633, P<0.01). Pearson correlation analysis showed that the level of TBA in the observation group was positively correlated with the level of NT-proBNP (r=0.539, P<0.01). ROC curve analysis showed that the area under the ROC curve with serum TBA+NT-proBNP combined detection was significantly larger than that of TBA and NT-proBNP used alone(0.942 vs. 0.728 and 0.912, P<0.05). Conclusions Serum TBA levels are significantly increased in CHF patients with T2DM and are positively correlated with cardiac function classification. Serum TBA and NT-proBNP levels can help predict the prognosis of CHF patients with T2DM, and combined detection is better.
YU Hong,ZHANG Jiao,ZHANG Lu等. Applicability of serum total bile acid and NT-proBNP levels in prognostic evaluation of patients with chronic heart failure and type 2 diabetes[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(11): 977-980.
Rao A, Kosters A, Mells J E, et al. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice [J]. Sci Transl Med, 2016, 8(357):122r-357r.
[5]
McGlone E R, Bloom S R. Bile acids and the metabolic syndrome [J]. Ann Clin Biochem,2019,56(3):326-337.
[6]
Shapiro H, Kolodziejczyk A A, Halstuch D, et al. Bile acids in glucose metabolism in health and disease [J]. J Exp Med, 2018, 215(2): 383-396.
Mayerhofer C, Ueland T, Broch K, et al. Increased secondary/primary bile acid ratio in chronic heart failure[J]. J Card Fail, 2017, 23(9):666-671.
[9]
Li W, Shu S, Cheng L, et al. Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions [J]. Atherosclerosis, 2020, 292:193-200.
Dauriz M, Mantovani A, Bonapace S, et al. Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis[J]. Diabetes Care, 2017, 40(11):1597-1605.
[14]
Chiang J, Ferrell J M. Bile acid metabolism in liver pathobiology[J]. Gene Exp, 2018, 18(2): 71-87.
[15]
Chavez-Talavera O, Tailleux A, Lefebvre P, et al. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease[J]. Gastroenterology, 2017,152(7):1679-1694.
[16]
Zhu W, Wang S, Dai H, et al. Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits [J]. J Diabetes, 2020,12(8): 616-625.
[17]
Sun W, Zhang D, Wang Z, et al. Insulin resistance is associated with total bile acid level in type 2 diabetic and nondiabetic population: a cross-sectional study [J]. Medicine (Baltimore), 2016, 95(10):e2778.
[18]
Sonne D P, van Nierop F S, Kulik W, et al. Postprandial plasma concentrations of individual bile acids and FGF-19 in patients with type 2 diabetes[J]. J Clin Endocrinol Metab, 2016, 101(8): 3002-3009.
[19]
Li T, Chanda D, Zhang Y, et al. Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes[J]. J Lipid Res,2010,51(4):832-842.
[20]
Li T, Kong X, Owsley E, et al. Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c [J]. J Biol Chem, 2006, 281(39): 28745-28754.
2021, Vol. 32 
